Back to Agenda
Session 5, Part 2: The Paradigm Shift: from Treatment to Prevention
Session Chair(s)
Michael Forstner, PHD, MPH, MSC
Managing Director, Head of Pharmacoepidemiology Practice, Mesa Laubela-Consulting, Switzerland
Maria Raad
Vice President, Customer and Digital Strategy, Janssen EMEA Commercial, Switzerland
Session 5, Part 2: The Paradigm Shift: from Treatment to Prevention
Speaker(s)
Christian Gossens, PHD
Global Area Head, Digital Biomarker Informatics, F. Hoffmann-La Roche Ltd., Switzerland
Setting the Scene: Digital Biomarkers in Clinical Research from a Pharma Industry Perspective
Foteini Orfaniotou
Group Digital Health Leader, F. Hoffmann-La Roche Ltd., Switzerland
Panel Discussion: Where are we with Digital Biomarkers for Disease Monitoring?
Christian Gossens, PHD
Global Area Head, Digital Biomarker Informatics, F. Hoffmann-La Roche Ltd., Switzerland
Trishna Bharadia
Patient Advocate, International Speaker, Writer, Advisor and Content Reviewer, The Spark Global, United Kingdom
Marcus D'Souza
Head Neurostatus-UHB, University Hospital Basel, Switzerland
Have an account?